Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomycin lung. New Zealand Clinical Oncology Group.
暂无分享,去创建一个
M. McKeage | C. Atkinson | P. Dady | B. Evans | G. Forgeson | D. Pérez | D. Perez | P. Dady | B. D. Evans | G. Forgeson | M J McKeage